lithium carbonate 300 MG Oral Tablet
1 INDICATIONS AND USAGE Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: • Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14 )] • Maintenance treatment in patients 7 years and older [see Clinical Studies ( 14 )] Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: • Treatment of acute manic and mixed episodes in patients 7 years and older ( 1 ) • Maintenance treatment in patients 7 years and older ( 1 )
West-Ward Pharmaceuticals Corp
ROUND WHITE 54 452
54 452 ROUND WHITE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Lithium Oral Solution USP, 8 mEq per 5 mL. Lithium Oral Solution, USP is supplied as a clear, colorless to slightly amber or red solution. NDC 0054-3527-63: Bottle of 500 mL Store and Dispense Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.] Dispense in a tight, child-resistant container as defined in the USP/NF.
LITHIUM CARBONATE Tablets, USP 300 mg supplied as white to off-white, biconvex tablet, scored on one side with product identification “54 452” debossed on the other side. NDC 0054-8528-25: 10x10 Unit-Dose (For Institutional Use Only) NDC 0054-4527-25: Bottle of 100 Tablets NDC 0054-4527-31: Bottle of 1,000 Tablets
LITHIUM CARBONATE capsules, USP 150 mg supplied as opaque white capsules imprinted with product identification “54 213” on both caps and bodies and containing a white powder. NDC 0054-8526-25: 10x10 Unit-Dose (For Institutional Use Only). NDC 0054-2526-25: Bottle of 100 capsules 300 mg supplied as opaque, light pink-colored capsules imprinted with product identification “54 463” on both caps and bodies and containing a white powder. NDC 0054-8527-25: 10x10 Unit-Dose (For Institutional Use Only). NDC 0054-2527-25: Bottle of 100 capsules NDC 0054-2527-31: Bottle of 1,000 capsules 600 mg supplied as gelatin capsules having opaque, light pink-colored caps with white bodies, imprinted with product identification “54 702” on both caps and bodies and containing a white powder. NDC 0054-8531-25: 10x10 Unit-Dose (For Institutional Use Only). NDC 0054-2531-25: Bottle of 100 capsules Storage Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.] Dispense in a tight, child-resistant container as defined in the USP/NF. PROTECT FROM MOISTURE.
More pills like ROUND 54 452